Takeda shatters tradition as GSK's Weber lined up as CEO
This article was originally published in Scrip
Executive Summary
By appointing Christophe Weber as chief operating officer and CEO-in-waiting, Takeda is sending a clear message: it is not afraid to break with Japanese industry tradition in its quest to become a leading global multinational pharmaceutical company.